Finally, to investigate whether semaglutide monotherapy or semaglutide in combination with BI8271, an NPY2R agonist (see electronic supplementary material [ESM] Methods: Diets and compounds), could also increase post-stroke neuronal survival, independently of metabolic effects, we determined their acute neuroprotective potential. The gene discussed is NPY2R; the disease is Stroke.